The estimated Net Worth of Funds, Lp Cable Car Capital... is at least $1.39 Milion dollars as of 22 September 2023. Funds Capital owns over 32,040 units of MEI Pharma Inc stock worth over $1,391,737 and over the last few years Funds sold MEIP stock worth over $0.
Funds has made over 2 trades of the MEI Pharma Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Funds bought 32,040 units of MEIP stock worth $219,474 on 22 September 2023.
The largest trade Funds's ever made was buying 102,400 units of MEI Pharma Inc stock on 20 September 2023 worth over $625,664. On average, Funds trades about 33,610 units every 1 days since 2023. As of 22 September 2023 Funds still owns at least 460,840 units of MEI Pharma Inc stock.
You can see the complete history of Funds Capital stock trades at the bottom of the page.
Over the last 12 years, insiders at MEI Pharma Inc have traded over $26,282,680 worth of MEI Pharma Inc stock and bought 597,450 units worth $2,541,200 . The most active insiders traders include Ventures Vii, Llc Vivo Vent..., Leaf Ventures Ii, L.P.New L... oraz Josiah T Austin. On average, MEI Pharma Inc executives and independent directors trade stock every 91 days with the average trade being worth of $360,383. The most recent stock trade was executed by Funds Management Lp Anson A... on 22 September 2023, trading 48,060 units of MEIP stock currently worth $329,211.
mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.
MEI Pharma Inc executives and other stock owners filed with the SEC include: